Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.1B |
| Enterprise Value | 954.31M |
| P/E Ratio | 4.84 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 1.22 |
| Price/Book Ratio | 0.75 |
| Enterprise/Revenue | 1.01 |
| Enterprise/EBITDA | 3.38 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.25 |
| Operating Margin | 0.26 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.16 |
Income Statement
| Revenue | 901.87M |
| Revenue/Share | 1.98 |
| Gross Profit | 757.67M |
| EBITDA | 294.19M |
| Net Income | 198.88M |
| Diluted EPS | 0.35 |
Balance Sheet
| Total Cash | 902.41M |
| Total Cash/Share | 1.61 |
| Total Debt | 399,926 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.47 |
| Book Value Per Share | 3.23 |
Price History
| 52-Week Change | 31.34 |
| 52-Week High | 3 |
| 52-Week Low | 1.82 |
| Moving Average 50 Days | 2.46 |
| Moving Average 200 Days | 2.35 |
Statistics
| Average Volume | 30,888 |
| Shares Outstanding | 560.25M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.24 |
| Trailing Annual Dividend Yield | 10.08 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
